Skip to main content
Log in

Substantial cost savings by better glycaemic control in T1DM

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study received financial support from Medtronic International Trading.

Reference

  • Choudhary P, et al. A modelling study of the budget impact of improved glycaemic control in adults with Type 1 diabetes in the UK. Diabetic Medicine : 2 Feb 2019. Available from: URL: http://doi.org/10.1111/dme.13924

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Substantial cost savings by better glycaemic control in T1DM. PharmacoEcon Outcomes News 822, 32 (2019). https://doi.org/10.1007/s40274-019-5684-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5684-1

Navigation